Doctors have announced the discovery of a new sub-type of the rare immune disorder Castleman’s disease, opening the way for improved treatments.
The new subtype has been named oligocentric Castleman’s disease (OligoCD). According to the researcher...
8 months ago
A new class of drugs may help in the treatment of acute myeloid leukaemia (AML), according to a joint UK-US project.
Researchers at Ludwig Institute for Cancer Research in Oxford, UK, have pinpointed GSK3 inhibitors as a potential combination ther...
8 months ago
